Kaido Kurrikoff

Vectiopep

BIOGRAPHY

Kaido Kurrikoff, the Founder and CEO of Vectiopep, leads the development of a peptide-based mRNA delivery platform for cancer immunotherapy and vaccines. His expertise spans cell-penetrating peptides, targeted nucleic acid delivery, and the translation of preclinical platforms into clinical programmes.

Kaido has over 15 years of experience as a Principal Investigator at the University of Tartu and has produced three commercialised IP inventions spanning drug delivery, biomanufacturing, and molecular diagnostics. His work focuses on platform translation, using technologies that achieve over 99% immune-cell selectivity for clinical mRNA cancer vaccines.